KRAS, TP53, CDKN2A, SMAD4, BRCA1, and BRCA2 Mutations in Pancreatic Cancer

By Cicenas Jonas   Kvederaviciute Kotryna   Meskinyte Ingrida   Meskinyte-Kausiliene Edita   Skeberdyte Aiste   Cicenas Jonas  

Cancers, Vol. 9, Iss. 5, 2017-04 ,pp. : 42-42

MDPI

Access to resources Recommend Favorite

Novel sequence variants and common recurrent polymorphisms of BRCA2 in Sri Lankan breast cancer patients and a family with BRCA1 mutations

By            

Experimental and Therapeutic Medicine, Vol. 2, Iss. 6, 2011-01 ,pp. : 1163-1170

Spandidos Publications

Access to resources Recommend Favorite

BRCA1 and BRCA2 germline mutations in Uruguayan breast and breast–ovarian cancer families. Identification of novel mutations and unclassified variants

By Delgado L.   Fernández G.   Grotiuz G.   Cataldi S.   González A.   LLuveras N.   Heguaburu M.   Fresco R.   Lens D.   Sabini G.   Muse I.  

Breast Cancer Research and Treatment, Vol. 128, Iss. 1, 2011-07 ,pp. : 211-218

Springer Publishing Company

Access to resources Recommend Favorite

Association study of type 2 diabetes genetic susceptibility variants and risk of pancreatic cancer: an analysis of PanScan-I data

By Pierce Brandon   Austin Melissa   Ahsan Habibul  

Cancer Causes and Control, Vol. 22, Iss. 6, 2011-06 ,pp. : 877-883

Springer Publishing Company

Access to resources Recommend Favorite

Genetic variants in FGFR2 and MAP3K1 are associated with the risk of familial and early-onset breast cancer in a South-American population

By Jara Lilian  

Breast Cancer Research and Treatment, Vol. 137, Iss. 2, 2013-01 ,pp. : 559-569

Springer Publishing Company

Access to resources Recommend Favorite